rs143796494

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_020066.5(FMN2):​c.5136T>G​(p.Ser1712Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00403 in 1,600,494 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0032 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0041 ( 25 hom. )

Consequence

FMN2
NM_020066.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.353

Publications

2 publications found
Variant links:
Genes affected
FMN2 (HGNC:14074): (formin 2) This gene is a member of the formin homology protein family. The encoded protein is thought to have essential roles in organization of the actin cytoskeleton and in cell polarity. This protein mediates the formation of an actin mesh that positions the spindle during oogenesis and also regulates the formation of actin filaments in the nucleus. This protein also forms a perinuclear actin/focal-adhesion system that regulates the shape and position of the nucleus during cell migration. Mutations in this gene have been associated with infertility and also with an autosomal recessive form of intellectual disability (MRT47). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jul 2017]
FMN2 Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal recessive 47
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 1-240472447-T-G is Benign according to our data. Variant chr1-240472447-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 435232.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.353 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00318 (484/152378) while in subpopulation NFE AF = 0.00506 (344/68040). AF 95% confidence interval is 0.00462. There are 2 homozygotes in GnomAd4. There are 206 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FMN2NM_020066.5 linkc.5136T>G p.Ser1712Ser synonymous_variant Exon 17 of 18 ENST00000319653.14 NP_064450.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FMN2ENST00000319653.14 linkc.5136T>G p.Ser1712Ser synonymous_variant Exon 17 of 18 5 NM_020066.5 ENSP00000318884.9

Frequencies

GnomAD3 genomes
AF:
0.00317
AC:
483
AN:
152260
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00386
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00442
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00506
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00323
AC:
783
AN:
242460
AF XY:
0.00330
show subpopulations
Gnomad AFR exome
AF:
0.000752
Gnomad AMR exome
AF:
0.00206
Gnomad ASJ exome
AF:
0.000205
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00497
Gnomad NFE exome
AF:
0.00508
Gnomad OTH exome
AF:
0.00504
GnomAD4 exome
AF:
0.00412
AC:
5971
AN:
1448116
Hom.:
25
Cov.:
27
AF XY:
0.00412
AC XY:
2966
AN XY:
720406
show subpopulations
African (AFR)
AF:
0.000394
AC:
13
AN:
32964
American (AMR)
AF:
0.00197
AC:
84
AN:
42674
Ashkenazi Jewish (ASJ)
AF:
0.000348
AC:
9
AN:
25884
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39406
South Asian (SAS)
AF:
0.0000120
AC:
1
AN:
83626
European-Finnish (FIN)
AF:
0.00596
AC:
318
AN:
53330
Middle Eastern (MID)
AF:
0.000350
AC:
2
AN:
5716
European-Non Finnish (NFE)
AF:
0.00479
AC:
5287
AN:
1104566
Other (OTH)
AF:
0.00429
AC:
257
AN:
59950
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
270
540
811
1081
1351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00318
AC:
484
AN:
152378
Hom.:
2
Cov.:
33
AF XY:
0.00276
AC XY:
206
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.000625
AC:
26
AN:
41598
American (AMR)
AF:
0.00392
AC:
60
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00442
AC:
47
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00506
AC:
344
AN:
68040
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00372
Hom.:
0
Bravo
AF:
0.00306

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FMN2: BP4, BP7, BS2 -

not specified Benign:1
Sep 30, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability, autosomal recessive 47 Benign:1
Mar 02, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
7.3
DANN
Benign
0.75
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143796494; hg19: chr1-240635747; API